References of "Dresse, Marie-Françoise"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailLE CANCER DU TRES JEUNE ENFANT : EPIDEMIOLOGIE LIEGEOISE
Fontaine, C; RIGO, Vincent ULg; FORGET, Patricia ULg et al

in Tijdschrift van de Belgische Kinderarts = Journal du Pédiatre Belge (2015), 17(1), 47

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailUTILISATION D'UNE FISTULE ARTERIO-VEINEUSE CHEZ DES PATIENTS DREPANOCYTAIRES SOUS ERYTHROCYTAPHERESE
Hoyoux, Marie; DRESSE, Marie-Françoise ULg; Minon, Jean-Marc et al

in Tijdschrift van de Belgische Kinderarts = Journal du Pédiatre Belge (2015), 17(1), 49

Detailed reference viewed: 11 (1 ULg)
Full Text
Peer Reviewed
See detailSurvival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment
Lê, Phu Quoc; Gulbis, Béatrice; Dedeken, Laurence et al

in Pediatric Blood & Cancer (2015), 62

Objective. To evaluate the survival of patients with sickle cell disease (SCD) recorded in the Belgian SCD Registry and to assess the impact of disease-modifying treatments (DMT). Method. The Registry ... [more ▼]

Objective. To evaluate the survival of patients with sickle cell disease (SCD) recorded in the Belgian SCD Registry and to assess the impact of disease-modifying treatments (DMT). Method. The Registry created in 2008 included patients of eight centers. All available data in 2008 were retrospectively encoded in the database. After 2008 and until 2012, all data were recorded prospectively for already registered patients as well as newly diagnosed subjects. Data were registered from neonatal screening or from diagnosis (first contact) until last follow-up or death. Data included diagnosis, demography, and outcome data. Results. We collected data from 469 patients over a 5,110 patient years (PY) follow-up period. The global mortality rate was low (0.25/100 PY), although 13 patients died (2.8%) and was similar between children, adolescents (10–18 years), and young adults (P¼0.76). Out of the cohort, 185 patients received hydroxyurea at last follow-up (median duration of treatment: 10.3 years), 90 underwent hematopoietic stem cell transplantation (HSCT), 24 were chronically transfused, and 170 had never had any DMT. Hydroxyurea showed significant benefit on patients outcome as reflected by a lower mortality rate compared to transplanted individuals or people without DMT (0.14, 0.36, and 0.38 per 100 PY, respectively) and by higher Kaplan–Meier estimates of 15 year survival (99.4%) compared to HSCT (93.8%; P¼0.01) or no DMT groups (95.4%; P¼0.04). Conclusion. SCD mortality in Belgium is low with no increase observed in young adults. Patients treated with hydroxyurea demonstrate a significant benefit in survival when compared to those withoutDMTor transplanted. [less ▲]

Detailed reference viewed: 23 (2 ULg)
Full Text
Peer Reviewed
See detailCOMMENT J’EXPLORE ET TRAITE UNE THROMBOSE VEINEUSE RÉNALE NÉONATALE : à propos d’un cas
Tribolet, S.; DRESSE, Marie-Françoise ULg; Lombet, J. et al

in Revue Médicale de Liège (2014), 69(4), 169-174

Neonatal renal vein thrombosis is a rare condition. The present case is rather unfrequent and particularly educative since it shows the complete diagnostic triad including hematuria, flank mass and ... [more ▼]

Neonatal renal vein thrombosis is a rare condition. The present case is rather unfrequent and particularly educative since it shows the complete diagnostic triad including hematuria, flank mass and thrombocytopenia. The diagnosis relies on the demonstration, by Doppler ultrasound, of an obstructed renal venous bed. The investigation is completed by a platelet count and the determination of the prothrombin time, of the activated partial thromboplastin time as well as of the concentration of fibrinogen. The screening also includes the search for a possible etiology, such as a deficiency in coagulation proteins, the presence of antiphospholipid antibodies or of a genetic mutation of one of the coagulation factors. Since there exist no evidence based guidelines for the management of the disease, we will discuss the diagnosis and treatment in relation with the published literature. [less ▲]

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailMinimal residual disease quantification by PCR in childhood acute lymphoblastic leukemia
Van der Straeten, J.; De Moerloose, B.; DRESSE, Marie-Françoise ULg et al

in Belgian Journal of Hematology (2014), 5

ln Belgium approximately 70 children are diagnosed with acute Iymphoblastic leukaemia annually. For these children, the monitoring of minimal residual disease has an important prognostic value. The level ... [more ▼]

ln Belgium approximately 70 children are diagnosed with acute Iymphoblastic leukaemia annually. For these children, the monitoring of minimal residual disease has an important prognostic value. The level of minimal residual disease during the first three months of therapy is used to recognise subgroups that differ substantially in outcome. Two techniques are used for minimal residual disease monitoring: the Genescan method and the allele specifie oligonucleotide polymerase chain reaction. The Genescan method is a less sensitive method (10-3) but is fast and less expensive. The allele specifie oligonucleotide polymerase chain reaction requires more time and budget but has a sensitivity of 10-4-10-5• Both techniques have proven their value in minimal residual disease monitoring in childhood acute Iymphoblastic leukaemia. [less ▲]

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailManaging children with chronic myeloid leukaemia (CML) Recommendations for the management of CML in children and young people up to the age of 18 years
de la Fuente, Josu; Baruchel, André; Biondi, Andrea et al

in British Journal of Haematology (2014), 167

Chronic myeloid leukaemia in children and young people is a relatively rare form of leukaemia that shows increased incidence with age and some evidence suggests that the molecular basis differs from that ... [more ▼]

Chronic myeloid leukaemia in children and young people is a relatively rare form of leukaemia that shows increased incidence with age and some evidence suggests that the molecular basis differs from that in adults. Significant advances in targeted therapy with the development and use in children of tyrosine kinase inhibitors and the ability to monitor and understand the prognostic significance of minimal residual disease by standardized molecular techniques has shifted the management of this condition from bone marrow transplantation as the main therapeutic modality to individualized treatment for each patient based on achieving specific milestones. The physiological changes occurring during childhood, particularly those affecting growth and development and the long-term use of treatment, pose specific challenges in this age group, which we are only beginning to understand. [less ▲]

Detailed reference viewed: 17 (2 ULg)
Full Text
Peer Reviewed
See detailOsteopetrosis mimicking juvenile myelomonocytic leukemia.
Hoyoux, Claire ULg; DRESSE, Marie-Françoise ULg; Forget, Patricia et al

in Pediatrics international : official journal of the Japan Pediatric Society (2014), 56(5), 779-82

A 5-month-old boy developed splenomegaly, anemia, thrombocytopenia with elevated white cells, monocytosis and immature granulocytes in the peripheral blood. Bone marrow showed dysplasia without blastosis ... [more ▼]

A 5-month-old boy developed splenomegaly, anemia, thrombocytopenia with elevated white cells, monocytosis and immature granulocytes in the peripheral blood. Bone marrow showed dysplasia without blastosis. Increased colony-forming unit-granulocyte-macrophage was found in the peripheral blood, mimicking granulocyte-macrophage colony-stimulating factor hypersensitivity. These findings fulfilled the diagnosis criteria for juvenile myelomonocytic leukemia (JMML), but no mutations in the CBL, NRAS, KRAS, or PTPN11 genes were detected. In addition to these findings severe hypogammaglobulinemia and elevated alkaline phosphatase were present. Bone X-ray showed dense and radiopaque bones with a bone-in-bone appearance characteristic of infantile malignant osteopetrosis (IMO). Genetic mutation in T-cell, immune regulator 1 (TCIRG1) was identified, confirming the diagnosis of IMO. Careful differential diagnosis including osteopetrosis, is therefore recommended in patients with clinical features and hematologic findings consistent with JMML. [less ▲]

Detailed reference viewed: 9 (2 ULg)
Full Text
Peer Reviewed
See detailPILOT PROJECT IN CHR-LIEGE: INVITING SIBLINGS OF CHILDREN WITH CANCER TO A CREATIVE AND EXPRESSIVE WEEK-END WITH PSYCHOLOGISTS AND ONCOLOGIST
Forget, Patricia; Badot, Isabelle; Missotten, Pierre ULg et al

Poster (2013, September 27)

The siblings week end with the psycho-medical team was highly successful It opens another way to improve the care of the siblings Questionnary forms should be developped in the future to evaluate the real ... [more ▼]

The siblings week end with the psycho-medical team was highly successful It opens another way to improve the care of the siblings Questionnary forms should be developped in the future to evaluate the real psychological impact [less ▲]

Detailed reference viewed: 52 (4 ULg)
Full Text
Peer Reviewed
See detailA 19-miRNA SIGNATURE PREDICTS RELAPSE IN AVERAGE RISK PRE-B ACUTE LYMPHOBLASTIC LEUKEMIA
Lammens, TL; Ghazavi, F; Suciu, S et al

in Tijdschrift van de Belgische Kinderarts = Journal du Pédiatre Belge (2012), 2012(4), 78

Detailed reference viewed: 21 (1 ULg)
Full Text
Peer Reviewed
See detailA Case of Osteosarcoma in a Patient With Pycnodysostosis
Cortisse, Natasha; FORGET, Patricia ULg; DRESSE, Marie-Françoise ULg et al

in American Journal of Pediatric Hematology/oncology (2012), 34

Pycnodysostosis is a rare sclerosing bone dystrophy. The main clinical features are short stature and oral and maxillofacial abnormalities such as a large head, a small and underdeveloped face with ... [more ▼]

Pycnodysostosis is a rare sclerosing bone dystrophy. The main clinical features are short stature and oral and maxillofacial abnormalities such as a large head, a small and underdeveloped face with prominent nose and eyes, irregular dentition, small hands and feet with dystrophic nails, and trunk deformities such as scoliosis. The differential diagnosis is established with other skeletal dysplasias such as osteopetrosis, cleidocranial dysplasia, and idiopathic acroosteolysis. Since its first description in 1962 by Maroteaux and Lamy, about 100 cases have been published, some of these with uncommon features. We describe the case of a 22-year-old European man with pycnodysostosis who developed a chondroblastic osteosarcoma of the right femur. No case of bone cancer in this sclerosing bone disease had been described so far. [less ▲]

Detailed reference viewed: 13 (2 ULg)
See detailLes soins à domicile en oncologie pédiatrique
DRESSE, Marie-Françoise ULg; Missotten, Pierre ULg; Janssen, Rita et al

Conference (2010, October 22)

Detailed reference viewed: 100 (21 ULg)
Full Text
Peer Reviewed
See detailEnfants en et hors traitements oncologiques : analyse comparative de leur qualité de vie et de leur vécu émotionnel
Missotten, Pierre ULg; Badot, Isabelle; Hoyoux, Claire et al

Poster (2010, May)

Detailed reference viewed: 75 (5 ULg)
Full Text
Peer Reviewed
See detailPerioperative management of a child with von Willebrand disease undergoing surgical repair of craniosynostosis: looking at unusual targets.
Maquoi, Isabelle ULg; Bonhomme, Vincent ULg; Born, Jacques Daniel et al

in Anesthesia and Analgesia (2009), 109(3), 720-4

We report the successful management of a craniosynostosis repair in a child with severe Type I von Willebrand disease diagnosed during the preoperative assessment and treated by coagulation factor VIII ... [more ▼]

We report the successful management of a craniosynostosis repair in a child with severe Type I von Willebrand disease diagnosed during the preoperative assessment and treated by coagulation factor VIII and ristocetin cofactor. Collaboration among the anesthesiologist, the neurosurgeon, the clinical pathologist, and the pediatric hematologist is important for successful management. [less ▲]

Detailed reference viewed: 67 (19 ULg)
Full Text
Peer Reviewed
See detailLa pyknocytose infantile : une anemie neonatale mal connue a propos de 5cas.
Limme, Boris ULg; Dresse, Marie-Françoise ULg; Ketelslegers, O. et al

in Archives de Pédiatrie (2008), 15(12), 1765-8

Infantile pyknocytosis (IP) is a rare hematological entity of newborns. It is a form of hemolytic anemia with unusual red cell morphology: the red blood cells are distorted, irregular, and small with many ... [more ▼]

Infantile pyknocytosis (IP) is a rare hematological entity of newborns. It is a form of hemolytic anemia with unusual red cell morphology: the red blood cells are distorted, irregular, and small with many projections. Spontaneous resolution usually occurs by 4-6months of age. OBSERVATION: We describe the clinical features and biological parameters of 5 cases of IP. The first symptoms were always early jaundice, which required phototherapy. Anemia was severe in all babies and red blood cell transfusion was needed. CONCLUSION: IP is a rare cause of neonatal anemia whose diagnosis is based on a careful peripheral blood smear examination. In our study, anemia was severe and required red blood cell transfusion. Ethnic specificity and familial occurrence are reported in our experience. [less ▲]

Detailed reference viewed: 451 (21 ULg)
Full Text
Peer Reviewed
See detailL’Inventaire Systémique de Qualité de Vie pour Enfants (ISQV-E©) : Etude de validation
Missotten, Pierre ULg; Lemétayer, Fabienne; Spitz, Elisabeth et al

Poster (2008, May)

Detailed reference viewed: 81 (2 ULg)
Full Text
Peer Reviewed
See detailManagement of diffuse glioma in children: a retrospective study of 27 cases and review of literature.
Piette, Caroline ULg; Deprez, Manuel ULg; Born, Jacques et al

in Acta Neurologica Belgica (2008), 108(2), 35-43

Gliomas are the most common CNS tumours in children and present either as circumscribed tumours or diffusely infiltrative neoplasms. Diffuse gliomas develop both in the cerebral hemispheres and the ... [more ▼]

Gliomas are the most common CNS tumours in children and present either as circumscribed tumours or diffusely infiltrative neoplasms. Diffuse gliomas develop both in the cerebral hemispheres and the brainstem and have a poor prognosis. Guidelines for the therapy of these tumours are still debated. In this study, we reviewed the clinical features of 27 consecutive patients with diffuse gliomas admitted to the Department of Paediatrics of CHR Citadelle, University of Liege, between 1985 and 2005. We review their clinical presentation, diagnosis, treatment and outcome with reference to the published literature. [less ▲]

Detailed reference viewed: 81 (12 ULg)
Full Text
Peer Reviewed
See detailPediatric gastric lymphoma: a rare entity.
Jacquemart, Caroline; Guidi, Ornella; Etienne, Isabelle et al

in Journal of Pediatric Hematology/Oncology : Official Journal of the American Society of Pediatric Hematology/Oncology (2008), 30(12), 984-6

Primary gastric lymphoma is a rare event in childhood. We describe a 13-year-old boy with gastric Burkitt-like lymphoma localized in the fundus. Symptoms mimicking gastritis-epigastric pain, hypochromic ... [more ▼]

Primary gastric lymphoma is a rare event in childhood. We describe a 13-year-old boy with gastric Burkitt-like lymphoma localized in the fundus. Symptoms mimicking gastritis-epigastric pain, hypochromic anemia, anorexia, and weight loss had been present for a few months before diagnosis. No Helicobacter pylori infection was shown at diagnosis. Biopsies obtained by ultrasound gastroscopy proved the diagnosis; F-fluorodeoxyglucose-positron emission tomography detected an isolated large gastric hypermetabolic mass. According to the international FAB/LMB 96 trial, the patient was treated with chemotherapy alone and is in first complete remission 2(1/2) years after diagnosis. [less ▲]

Detailed reference viewed: 9 (0 ULg)
Full Text
Peer Reviewed
See detailCord blood transplantation in a child with Pearson's disease.
Hoyoux, Claire; Dresse, Marie-Françoise ULg; Robinet, Sébastien ULg et al

in Pediatric Blood & Cancer (2008), 51(4), 566

Detailed reference viewed: 48 (8 ULg)
Full Text
Peer Reviewed
See detailPrise en charge du médulloblastome de l'enfant
Fransolet, A. C.; Born, J. D.; Misson, Jean-Paul ULg et al

in Revue Médicale de Liège (2007), 62(4), 200-4

We present the experience of the Citadelle Hospital (Liege, B) in the diagnosis, treatment and follow-up of medulloblastoma in children. A retrospective study of 10 cases of medulloblastoma was performed ... [more ▼]

We present the experience of the Citadelle Hospital (Liege, B) in the diagnosis, treatment and follow-up of medulloblastoma in children. A retrospective study of 10 cases of medulloblastoma was performed. Five years after diagnosis, the event-free survival was 77%. [less ▲]

Detailed reference viewed: 157 (2 ULg)